Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Chappell Dale | Chief Scientific Officer | 119 | $5.28M | $68.76M | 2023-10-18 |
| Kilcoyne Adrian | Chief Medical Officer | 8 | $31.6K | $0 | 2022-07-27 |
| Buxton Cheryl | Director | 6 | $0 | $0 | 2022-07-27 |
| Xie Yili Kevin | Director | 3 | $0 | $0 | 2022-07-27 |
| Boehm Rainer J. | Director | 14 | $0 | $0 | 2022-07-27 |
| Hohneker John | Director | 3 | $0 | $0 | 2022-07-27 |
| Jordan Edward P. | Chief Commercial Officer | 10 | $29.0K | $295.2K | 2022-07-27 |
| Durrant Cameron | Chief Executive Officer | 29 | $93.6K | $1.68M | 2022-07-27 |
| BARLIANT RONALD | Director | 16 | $0 | $0 | 2022-07-27 |
| MORRIS TIMOTHY E | Director | 6 | $0 | $0 | 2022-07-27 |
| NOMIS BAY LTD. | 10% Owner | 62 | $8.37M | $2.53B | 2021-03-11 |
| Tousley David L. | See Remarks | 1 | $0 | $0 | 2020-09-18 |
| Savage Robert G. | Director | 9 | $0 | $0 | 2020-04-01 |
| BLACK HORSE CAPITAL MANAGEMENT LLC | 10% Owner | 2 | $0 | $0 | 2019-05-31 |
| Jester J Gregory | Chief Financial Officer | 4 | $0 | $0 | 2019-01-25 |
| Cheval Holdings, Ltd. | 10% Owner | 4 | $2.88M | $0 | 2018-02-27 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Chappell Dale | Chief Scientific Officer | S Sale | 2023-10-18 | 2023-10-20 | 34,253 | $0.01 | $343 | 1,041,536 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2023-10-18 | 2023-10-20 | 276,210 | $0.01 | $2.8K | 8,398,871 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2023-10-18 | 2023-10-20 | 75,887 | $0.01 | $759 | 2,307,530 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award deriv | 2022-07-27 | 2022-07-29 | 808,906 | — | $0 | 808,906 | SEC↗ |
| Xie Yili Kevin | Director | A Award deriv | 2022-07-27 | 2022-07-29 | 83,418 | — | $0 | 83,418 | SEC↗ |
| MORRIS TIMOTHY E | COO and CFO | A Award deriv | 2022-07-27 | 2022-07-29 | 600,360 | — | $0 | 600,360 | SEC↗ |
| Jordan Edward P. | Chief Commercial Officer | A Award deriv | 2022-07-27 | 2022-07-29 | 455,010 | — | $0 | 455,010 | SEC↗ |
| Boehm Rainer J. | Director | A Award deriv | 2022-07-27 | 2022-07-29 | 73,307 | — | $0 | 73,307 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | A Award deriv | 2022-07-27 | 2022-07-29 | 518,205 | — | $0 | 518,205 | SEC↗ |
| BARLIANT RONALD | Director | A Award deriv | 2022-07-27 | 2022-07-29 | 55,612 | — | $0 | 55,612 | SEC↗ |
| Buxton Cheryl | Director | A Award deriv | 2022-07-27 | 2022-07-29 | 78,362 | — | $0 | 78,362 | SEC↗ |
| Kilcoyne Adrian | Chief Medical Officer | A Award deriv | 2022-07-27 | 2022-07-29 | 537,164 | — | $0 | 537,164 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2022-07-27 | 2022-07-29 | 63,195 | — | $0 | 63,195 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-05-20 | 2022-05-20 | 54,549 | $2.23 | $121.6K | 1,075,789 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-05-20 | 2022-05-20 | 109,098 | $2.23 | $243.3K | 2,383,417 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-05-20 | 2022-05-20 | 381,841 | $2.23 | $851.5K | 8,675,081 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-05-19 | 2022-05-20 | 32,381 | $2.19 | $70.9K | 1,021,240 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-05-19 | 2022-05-20 | 226,665 | $2.19 | $496.4K | 8,293,240 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-05-19 | 2022-05-20 | 64,762 | $2.19 | $141.8K | 2,274,319 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-05-18 | 2022-05-20 | 34,740 | $1.96 | $68.1K | 2,209,557 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-05-18 | 2022-05-20 | 17,370 | $1.96 | $34.0K | 988,859 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-05-18 | 2022-05-20 | 121,590 | $1.96 | $238.3K | 8,066,575 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-03-11 | 2022-03-15 | 200,000 | $3.00 | $600.0K | 2,174,817 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-03-11 | 2022-03-15 | 700,000 | $3.00 | $2.10M | 7,944,985 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy | 2022-03-11 | 2022-03-15 | 100,000 | $3.00 | $300.0K | 971,489 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-10 | 2022-03-10 | 550 | $0.75 | $413 | 2,866 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-10 | 2022-03-10 | 157 | $0.75 | $118 | 818 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-10 | 2022-03-10 | 79 | $0.75 | $59 | 410 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-09 | 2022-03-10 | 36 | $1.20 | $43 | 7,393 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-09 | 2022-03-10 | 1,026 | $0.79 | $811 | 2,316 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-09 | 2022-03-10 | 293 | $0.79 | $231 | 661 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-09 | 2022-03-10 | 10 | $1.20 | $12 | 2,111 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-09 | 2022-03-10 | 5 | $1.20 | $6 | 1,055 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-09 | 2022-03-10 | 147 | $0.79 | $116 | 331 | SEC↗ |
| Kilcoyne Adrian | Chief Medical Officer | P Buy | 2022-03-09 | 2022-03-14 | 5,000 | $2.78 | $13.9K | 12,000 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-08 | 2022-03-10 | 1,668 | $1.20 | $2.0K | 7,357 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-08 | 2022-03-10 | 476 | $1.20 | $571 | 2,101 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-08 | 2022-03-10 | 238 | $1.20 | $286 | 1,050 | SEC↗ |
| Kilcoyne Adrian | Chief Medical Officer | P Buy | 2022-03-08 | 2022-03-14 | 7,000 | $2.53 | $17.7K | 7,000 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-04 | 2022-03-04 | 891 | $0.90 | $802 | 5,689 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-04 | 2022-03-04 | 255 | $0.90 | $230 | 1,625 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-04 | 2022-03-04 | 127 | $0.90 | $114 | 812 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-03 | 2022-03-04 | 173 | $0.35 | $61 | 184 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-03 | 2022-03-04 | 1,213 | $0.35 | $425 | 1,290 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-03 | 2022-03-04 | 36 | $0.70 | $25 | 4,798 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-03 | 2022-03-04 | 346 | $0.35 | $121 | 368 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-03 | 2022-03-04 | 10 | $0.70 | $7 | 1,370 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-03 | 2022-03-04 | 5 | $0.70 | $4 | 685 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-02 | 2022-03-04 | 680 | $0.60 | $408 | 680 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-02 | 2022-03-04 | 77 | $0.33 | $25 | 77 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-02 | 2022-03-04 | 4,762 | $0.60 | $2.9K | 4,762 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-02 | 2022-03-04 | 22 | $0.33 | $7 | 22 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-02 | 2022-03-04 | 1,360 | $0.60 | $816 | 1,360 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | P Buy deriv | 2022-03-02 | 2022-03-04 | 11 | $0.33 | $4 | 11 | SEC↗ |
| Jordan Edward P. | Chief Commercial Officer | P Buy | 2022-03-02 | 2022-03-04 | 12,500 | $2.32 | $29.0K | 12,500 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | P Buy | 2022-03-02 | 2022-03-04 | 40,000 | $2.34 | $93.6K | 70,000 | SEC↗ |
| Kilcoyne Adrian | Chief Medical Officer | A Award deriv | 2022-01-12 | 2022-01-14 | 38,411 | — | $0 | 38,411 | SEC↗ |
| Jordan Edward P. | Chief Commercial Officer | A Award deriv | 2022-01-12 | 2022-01-14 | 43,763 | — | $0 | 43,763 | SEC↗ |
| MORRIS TIMOTHY E | COO and CFO | A Award deriv | 2022-01-12 | 2022-01-14 | 59,841 | — | $0 | 59,841 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | A Award deriv | 2022-01-12 | 2022-01-14 | 36,550 | — | $0 | 36,550 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award deriv | 2022-01-12 | 2022-01-14 | 84,385 | — | $0 | 84,385 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award deriv | 2021-12-31 | 2022-01-04 | 76,000 | — | $0 | 76,000 | SEC↗ |
| MORRIS TIMOTHY E | COO and CFO | A Award deriv | 2021-12-31 | 2022-01-04 | 51,000 | — | $0 | 51,000 | SEC↗ |
| Kilcoyne Adrian | Chief Medical Officer | A Award deriv | 2021-12-31 | 2022-01-04 | 34,500 | — | $0 | 34,500 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | A Award deriv | 2021-12-31 | 2022-01-04 | 44,600 | — | $0 | 44,600 | SEC↗ |
| Jordan Edward P. | Chief Commercial Officer | A Award deriv | 2021-12-31 | 2022-01-04 | 29,400 | — | $0 | 29,400 | SEC↗ |
| Boehm Rainer J. | Director | A Award deriv | 2021-12-31 | 2022-01-04 | 5,117 | $2.84 | $14.5K | 5,117 | SEC↗ |
| BARLIANT RONALD | Director | A Award deriv | 2021-12-31 | 2022-01-04 | 4,163 | $2.84 | $11.8K | 4,163 | SEC↗ |
| Buxton Cheryl | Director | A Award deriv | 2021-12-31 | 2022-01-04 | 5,523 | $2.84 | $15.7K | 5,523 | SEC↗ |
| Xie Yili Kevin | Director | A Award deriv | 2021-12-31 | 2022-01-04 | 4,674 | $2.84 | $13.3K | 4,674 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2021-12-31 | 2022-01-04 | 3,538 | $2.84 | $10.0K | 3,538 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | D To issuer deriv | 2021-11-23 | 2021-11-26 | 17,660 | $4.53 | $80.0K | 0 | SEC↗ |
| Jordan Edward P. | Chief Commercial Officer | D To issuer deriv | 2021-11-23 | 2021-11-26 | 4,966 | $4.53 | $22.5K | 0 | SEC↗ |
| Kilcoyne Adrian | Chief Medical Officer | D To issuer deriv | 2021-11-23 | 2021-11-26 | 5,863 | $4.53 | $26.6K | 0 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2021-10-19 | 2021-10-20 | 42,866 | — | $0 | 42,866 | SEC↗ |
| Xie Yili Kevin | Director | A Award deriv | 2021-10-19 | 2021-10-20 | 42,866 | — | $0 | 42,866 | SEC↗ |
| Kilcoyne Adrian | Chief Medical Officer | A Award deriv | 2021-09-30 | 2021-10-04 | 5,863 | — | $0 | 5,863 | SEC↗ |
| Jordan Edward P. | Chief Commercial Officer | A Award deriv | 2021-09-30 | 2021-10-04 | 4,966 | — | $0 | 4,966 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award deriv | 2021-09-30 | 2021-10-04 | 17,660 | — | $0 | 17,660 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | A Award deriv | 2021-09-30 | 2021-10-04 | 22,626 | — | $0 | 22,626 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-08-12 | 2021-08-13 | 11,510 | $17.16 | $197.5K | 1,980,696 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-08-12 | 2021-08-13 | 41,725 | $17.16 | $716.0K | 7,266,296 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-08-12 | 2021-08-13 | 4,316 | $17.16 | $74.1K | 873,693 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-08-11 | 2021-08-13 | 21,929 | $17.07 | $374.3K | 1,992,206 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-08-11 | 2021-08-13 | 79,494 | $17.07 | $1.36M | 7,308,021 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-08-11 | 2021-08-13 | 8,224 | $17.07 | $140.4K | 878,009 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-29 | 2021-07-30 | 5,879 | $17.03 | $100.1K | 2,008,256 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-29 | 2021-07-30 | 21,311 | $17.03 | $362.9K | 7,366,204 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-29 | 2021-07-30 | 2,204 | $17.03 | $37.5K | 884,029 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-28 | 2021-07-30 | 1,938 | $17.04 | $33.0K | 2,014,135 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-28 | 2021-07-30 | 727 | $17.04 | $12.4K | 886,233 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-28 | 2021-07-30 | 7,027 | $17.04 | $119.7K | 7,387,515 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-23 | 2021-07-23 | 1,117 | $17.04 | $19.0K | 2,016,073 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-23 | 2021-07-23 | 4,048 | $17.04 | $69.0K | 7,394,542 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-23 | 2021-07-23 | 419 | $17.04 | $7.1K | 886,960 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-22 | 2021-07-23 | 35,601 | $17.04 | $606.6K | 2,017,190 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-22 | 2021-07-23 | 13,350 | $17.04 | $227.5K | 887,379 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-22 | 2021-07-23 | 129,054 | $17.04 | $2.20M | 7,398,590 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-21 | 2021-07-23 | 26,553 | $17.14 | $455.1K | 2,052,791 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-21 | 2021-07-23 | 9,957 | $17.14 | $170.7K | 900,729 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-21 | 2021-07-23 | 96,254 | $17.14 | $1.65M | 7,527,644 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-14 | 2021-07-16 | 3,036 | $17.06 | $51.8K | 2,079,344 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-14 | 2021-07-16 | 11,003 | $17.06 | $187.7K | 7,623,898 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-14 | 2021-07-16 | 1,138 | $17.06 | $19.4K | 910,686 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-09 | 2021-07-09 | 214,626 | $17.37 | $3.73M | 7,634,901 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-09 | 2021-07-09 | 59,207 | $17.37 | $1.03M | 2,082,380 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-09 | 2021-07-09 | 22,203 | $17.37 | $385.7K | 911,824 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-08 | 2021-07-09 | 34,807 | $17.17 | $597.6K | 7,849,527 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-08 | 2021-07-09 | 9,602 | $17.17 | $164.9K | 2,141,587 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-08 | 2021-07-09 | 3,601 | $17.17 | $61.8K | 934,027 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-02 | 2021-07-02 | 74,565 | $17.12 | $1.28M | 7,884,334 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-02 | 2021-07-02 | 20,569 | $17.12 | $352.1K | 2,151,189 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-02 | 2021-07-02 | 7,714 | $17.12 | $132.1K | 937,628 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-01 | 2021-07-02 | 28,198 | $17.10 | $482.2K | 2,171,758 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-01 | 2021-07-02 | 10,575 | $17.10 | $180.8K | 945,342 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-07-01 | 2021-07-02 | 102,219 | $17.10 | $1.75M | 7,958,899 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-30 | 2021-07-02 | 43,851 | $17.28 | $757.7K | 2,199,956 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-30 | 2021-07-02 | 16,444 | $17.28 | $284.2K | 955,917 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-30 | 2021-07-02 | 158,961 | $17.28 | $2.75M | 8,061,118 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-25 | 2021-06-25 | 75,000 | $17.80 | $1.33M | 972,361 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-25 | 2021-06-25 | 200,000 | $17.80 | $3.56M | 2,243,807 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-25 | 2021-06-25 | 725,000 | $17.80 | $12.90M | 8,220,079 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-24 | 2021-06-25 | 10,465 | $18.37 | $192.2K | 1,047,361 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-24 | 2021-06-25 | 101,158 | $18.37 | $1.86M | 8,945,079 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-24 | 2021-06-25 | 27,906 | $18.37 | $512.6K | 2,443,807 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-23 | 2021-06-25 | 26,625 | $18.28 | $486.7K | 2,471,713 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-23 | 2021-06-25 | 96,516 | $18.28 | $1.76M | 9,046,237 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-23 | 2021-06-25 | 9,985 | $18.28 | $182.5K | 1,057,826 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-18 | 2021-06-21 | 80,496 | $18.50 | $1.49M | 2,498,338 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-18 | 2021-06-21 | 291,798 | $18.50 | $5.40M | 9,142,753 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-18 | 2021-06-21 | 30,186 | $18.50 | $558.4K | 1,067,811 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-17 | 2021-06-21 | 36,284 | $19.17 | $695.6K | 2,578,834 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-17 | 2021-06-21 | 131,532 | $19.17 | $2.52M | 9,434,551 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-17 | 2021-06-21 | 13,607 | $19.17 | $260.8K | 1,097,997 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-16 | 2021-06-21 | 111,325 | $19.40 | $2.16M | 9,566,083 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-16 | 2021-06-21 | 34,431 | $19.40 | $668.0K | 2,615,118 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-16 | 2021-06-21 | 12,730 | $19.50 | $248.2K | 1,111,604 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | S Sale | 2021-06-14 | 2021-06-16 | 49,906 | $20.61 | $1.03M | 30,000 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | S Sale | 2021-06-14 | 2021-06-16 | 5,094 | $21.14 | $107.7K | 79,906 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | S Sale | 2021-06-14 | 2021-06-16 | 26,441 | $20.60 | $544.7K | 85,000 | SEC↗ |
| Jordan Edward P. | Chief Commercial Officer | M Exercise deriv | 2021-06-08 | 2021-06-09 | 14,700 | — | $0 | 73,500 | SEC↗ |
| Jordan Edward P. | Chief Commercial Officer | S Sale | 2021-06-08 | 2021-06-09 | 14,700 | $20.08 | $295.2K | 0 | SEC↗ |
| Jordan Edward P. | Chief Commercial Officer | M Exercise | 2021-06-08 | 2021-06-09 | 14,700 | $9.65 | $141.9K | 14,700 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-07 | 2021-06-09 | 12,732 | $19.08 | $242.9K | 1,124,334 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-07 | 2021-06-09 | 42,440 | $19.08 | $809.8K | 9,677,408 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-07 | 2021-06-09 | 25,464 | $19.08 | $485.9K | 2,649,549 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-04 | 2021-06-04 | 40,132 | $18.46 | $740.8K | 2,675,013 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-04 | 2021-06-04 | 66,886 | $18.46 | $1.23M | 9,719,848 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-04 | 2021-06-04 | 20,066 | $18.46 | $370.4K | 1,137,066 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-03 | 2021-06-04 | 60,365 | $18.37 | $1.11M | 2,715,145 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-03 | 2021-06-04 | 30,182 | $18.37 | $554.4K | 1,157,132 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-03 | 2021-06-04 | 100,607 | $18.37 | $1.85M | 9,786,734 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-02 | 2021-06-04 | 40,042 | $19.01 | $761.2K | 9,887,341 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-02 | 2021-06-04 | 12,028 | $19.01 | $228.7K | 1,187,314 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | S Sale | 2021-06-02 | 2021-06-04 | 24,056 | $19.01 | $457.3K | 2,775,510 | SEC↗ |
| Kilcoyne Adrian | Chief Medical Officer | A Award deriv | 2021-04-21 | 2021-04-22 | 155,000 | — | $0 | 155,000 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award deriv | 2021-03-12 | 2021-03-15 | 652,640 | — | $0 | 652,640 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-03-11 | 2021-03-11 | 119,201 | $16.02 | $1.91M | 5,380,799 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | J Other | 2021-03-11 | 2021-03-11 | 37,912 | $15.49 | $587.3K | 5,342,887 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-03-10 | 2021-03-11 | 32,469 | $16.46 | $534.4K | 5,500,000 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-03-09 | 2021-04-06 | 83,568 | $17.24 | $1.44M | 5,632,469 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-03-09 | 2021-03-11 | 83,568 | $17.24 | $1.44M | 55,632,469 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | G Gift | 2021-03-01 | 2021-06-16 | 111,441 | — | $0 | 111,441 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | G Gift | 2021-03-01 | 2021-06-16 | 111,441 | — | $0 | 0 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-03-01 | 2021-03-01 | 14,100 | $18.65 | $263.0K | 5,616,037 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-26 | 2021-03-01 | 30,003 | $19.18 | $575.5K | 5,630,137 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-25 | 2021-03-01 | 2,402 | $19.17 | $46.0K | 5,660,140 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-24 | 2021-02-24 | 25,906 | $19.55 | $506.5K | 5,662,542 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-22 | 2021-02-24 | 77,314 | $23.21 | $1.79M | 5,688,448 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-19 | 2021-02-19 | 37,300 | $23.50 | $876.5K | 5,765,762 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-18 | 2021-02-19 | 42,408 | $21.70 | $920.3K | 5,803,062 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-17 | 2021-02-19 | 9,700 | $19.92 | $193.2K | 5,845,470 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-13 | 2021-02-16 | 16,423 | $19.68 | $323.2K | 5,855,170 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-11 | 2021-02-16 | 550 | $21.01 | $11.6K | 5,871,593 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-10 | 2021-02-10 | 10,875 | $21.39 | $232.6K | 5,872,143 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-09 | 2021-02-10 | 25,666 | $22.32 | $572.9K | 5,883,018 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-08 | 2021-02-10 | 17,732 | $20.70 | $367.1K | 5,908,684 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-04 | 2021-02-04 | 47,862 | $21.88 | $1.05M | 5,926,416 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-03 | 2021-02-04 | 25,000 | $19.23 | $480.8K | 5,974,278 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-02-02 | 2021-02-04 | 722 | $20.03 | $14.5K | 5,999,278 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-01-25 | 2021-01-27 | 23,140 | $19.23 | $445.0K | 6,070,000 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | J Other | 2021-01-25 | 2021-01-27 | 70,000 | $18.78 | $1.31M | 6,000,000 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-01-22 | 2021-01-27 | 71,892 | $20.08 | $1.44M | 6,093,140 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-01-20 | 2021-01-21 | 2,500 | $18.37 | $45.9K | 6,165,032 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-01-19 | 2021-01-19 | 50,000 | $19.81 | $990.5K | 6,173,532 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-01-19 | 2021-01-21 | 6,000 | $21.08 | $126.5K | 6,167,532 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-01-15 | 2021-01-19 | 30,000 | $18.23 | $546.9K | 6,223,532 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-01-14 | 2021-01-19 | 25,000 | $18.07 | $451.8K | 6,253,532 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-01-12 | 2021-01-13 | 14,577 | $18.43 | $268.7K | 6,278,532 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2021-01-11 | 2021-01-13 | 10,423 | $19.00 | $198.0K | 6,293,109 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-12-28 | 2020-12-31 | 500 | $22.20 | $11.1K | 6,303,532 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-12-24 | 2020-12-28 | 8,401 | $22.05 | $185.2K | 6,304,032 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-12-23 | 2020-12-28 | 45,000 | $21.09 | $949.0K | 6,312,433 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-12-22 | 2020-12-23 | 50,000 | $50000.00 | $2.50B | 6,357,433 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-12-22 | 2020-12-28 | 50,000 | $20.02 | $1.00M | 6,357,433 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-12-21 | 2020-12-23 | 25,000 | $19.46 | $486.5K | 6,407,433 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | X Exercise deriv | 2020-12-18 | 2020-12-23 | 46 | — | $0 | 0 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | X Exercise deriv | 2020-12-18 | 2020-12-23 | 100 | — | $0 | 203 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | X Exercise deriv | 2020-12-18 | 2020-12-23 | 70 | — | $0 | 303 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | X Exercise deriv | 2020-12-18 | 2020-12-23 | 157 | — | $0 | 46 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-12-18 | 2020-12-23 | 62,700 | $15.76 | $988.2K | 6,469,733 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | X Exercise | 2020-12-18 | 2020-12-23 | 37,300 | $15.00 | $559.5K | 6,432,433 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale deriv | 2020-12-17 | 2020-12-23 | 46 | $0.15 | $7 | 373 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale deriv | 2020-12-15 | 2020-12-23 | 157 | $0.40 | $63 | 327 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale deriv | 2020-12-10 | 2020-12-23 | 100 | $0.10 | $10 | 170 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale deriv | 2020-12-07 | 2020-12-23 | 70 | $0.10 | $7 | 70 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award deriv | 2020-10-05 | 2020-10-07 | 82,622 | — | $0 | 82,622 | SEC↗ |
| BARLIANT RONALD | Director | A Award deriv | 2020-09-30 | 2020-10-02 | 1,803 | $8.04 | $14.5K | 1,803 | SEC↗ |
| Boehm Rainer J. | Director | A Award | 2020-09-30 | 2020-10-02 | 1,519 | $10.64 | $16.2K | 84,986 | SEC↗ |
| Buxton Cheryl | Director | A Award | 2020-09-30 | 2020-10-02 | 1,284 | $10.64 | $13.7K | 4,364 | SEC↗ |
| Jordan Edward P. | Chief Commercial Officer | A Award deriv | 2020-09-18 | 2020-09-22 | 88,200 | — | $0 | 88,200 | SEC↗ |
| MORRIS TIMOTHY E | COO and CFO | A Award deriv | 2020-09-18 | 2020-09-22 | 151,316 | — | $0 | 151,316 | SEC↗ |
| Tousley David L. | See Remarks | A Award deriv | 2020-09-18 | 2020-09-22 | 62,700 | — | $0 | 62,700 | SEC↗ |
| Chappell Dale | Chief Scientific Officer | A Award deriv | 2020-09-18 | 2020-09-22 | 133,760 | $9.65 | $1.29M | 133,760 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-08-10 | 2020-08-12 | 17,100 | $5.04 | $86.2K | 32,662,170 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-07-28 | 2020-07-30 | 10,000 | $5.66 | $56.6K | 32,679,270 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-07-20 | 2020-07-21 | 261,915 | $5.00 | $1.31M | 32,689,270 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-07-17 | 2020-07-21 | 38,085 | $5.01 | $190.8K | 32,951,185 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-06-30 | 2020-07-02 | 3,000 | $4.91 | $14.7K | 32,989,270 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-06-16 | 2020-06-17 | 35,000 | $5.73 | $200.6K | 32,992,270 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-06-15 | 2020-06-17 | 30,000 | $5.50 | $165.0K | 33,027,270 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-06-10 | 2020-06-12 | 5,000 | $3.48 | $17.4K | 33,057,270 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-06-09 | 2020-06-12 | 35,000 | $3.65 | $127.8K | 33,062,270 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-06-04 | 2020-06-12 | 106,000 | $3.03 | $321.2K | 33,097,270 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-06-03 | 2020-06-12 | 101,010 | $2.98 | $301.0K | 33,203,270 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-06-02 | 2020-06-12 | 263,250 | $2.18 | $573.9K | 33,304,280 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award deriv | 2020-05-20 | 2020-05-21 | 250,000 | $0.86 | $215.0K | 250,000 | SEC↗ |
| BARLIANT RONALD | Director | A Award | 2020-05-20 | 2020-05-22 | 26,847 | $0.86 | $23.1K | 449,351 | SEC↗ |
| Chappell Dale | 10% Owner | C Conversion deriv | 2020-04-02 | 2020-04-07 | 0 | $500000.00 | $0 | 0 | SEC↗ |
| Chappell Dale | 10% Owner | C Conversion | 2020-04-02 | 2020-04-07 | 1,583,333 | $0.36 | $570.0K | 49,636,917 | SEC↗ |
| BARLIANT RONALD | Director | A Award deriv | 2020-04-01 | 2020-04-02 | 48,214 | $1.20 | $57.9K | 48,214 | SEC↗ |
| Savage Robert G. | Director | A Award deriv | 2020-04-01 | 2020-04-02 | 66,071 | $1.20 | $79.3K | 66,071 | SEC↗ |
| BARLIANT RONALD | Director | A Award deriv | 2020-04-01 | 2020-04-07 | 15,340 | $1.20 | $18.4K | 15,340 | SEC↗ |
| Savage Robert G. | Director | A Award deriv | 2020-04-01 | 2020-04-07 | 21,022 | $1.20 | $25.2K | 21,022 | SEC↗ |
| Boehm Rainer J. | Director | A Award | 2020-04-01 | 2020-04-02 | 13,750 | $1.20 | $16.5K | 417,338 | SEC↗ |
| Buxton Cheryl | Director | A Award | 2020-04-01 | 2020-04-02 | 10,824 | $1.20 | $13.0K | 15,400 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2020-03-20 | 2020-06-12 | 6,000 | $2.00 | $12.0K | 33,567,530 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award deriv | 2020-01-28 | 2020-01-29 | 318,103 | $0.40 | $127.2K | 318,103 | SEC↗ |
| BARLIANT RONALD | Director | A Award deriv | 2020-01-22 | 2020-01-24 | 50,000 | $0.38 | $19.0K | 50,000 | SEC↗ |
| Buxton Cheryl | Director | A Award | 2020-01-22 | 2020-01-24 | 4,576 | $0.38 | $1.7K | 4,576 | SEC↗ |
| Boehm Rainer J. | Director | A Award | 2020-01-22 | 2020-01-24 | 43,421 | $0.38 | $16.5K | 403,588 | SEC↗ |
| Buxton Cheryl | Director | A Award deriv | 2019-12-16 | 2019-12-16 | 715,877 | — | $0 | 715,877 | SEC↗ |
| BARLIANT RONALD | Director | A Award deriv | 2019-11-08 | 2019-11-12 | 26,470 | $0.51 | $13.5K | 26,470 | SEC↗ |
| Boehm Rainer J. | Director | A Award | 2019-11-08 | 2019-11-12 | 23,571 | $0.70 | $16.5K | 360,167 | SEC↗ |
| BARLIANT RONALD | Director | A Award | 2019-07-29 | 2019-07-31 | 15,882 | $0.85 | $13.5K | 422,504 | SEC↗ |
| Boehm Rainer J. | Director | A Award | 2019-07-29 | 2019-07-31 | 19,412 | $0.85 | $16.5K | 336,596 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award | 2019-06-04 | 2019-06-05 | 8,000 | $1.25 | $10.0K | 557,207 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | J Other | 2019-05-31 | 2019-05-31 | 235,624 | — | $0 | 549,207 | SEC↗ |
| BARLIANT RONALD | Director | J Other | 2019-05-31 | 2019-05-31 | 236,499 | — | $0 | 406,622 | SEC↗ |
| BLACK HORSE CAPITAL MANAGEMENT | 10% Owner | J Other | 2019-05-31 | 2019-06-04 | 591,248 | — | $0 | 47,467,557 | SEC↗ |
| BLACK HORSE CAPITAL MANAGEMENT | 10% Owner | J Other | 2019-05-31 | 2019-06-04 | 586,027 | — | $0 | 48,053,584 | SEC↗ |
| Boehm Rainer J. | Director | M Exercise deriv | 2019-05-29 | 2019-05-30 | 238,625 | — | $0 | 477,252 | SEC↗ |
| Boehm Rainer J. | Director | A Award | 2019-05-29 | 2019-05-30 | 238,625 | $0.67 | $159.9K | 317,184 | SEC↗ |
| Savage Robert G. | Director | M Exercise deriv | 2019-05-14 | 2019-05-16 | 100,000 | — | $0 | 615,877 | SEC↗ |
| Savage Robert G. | Director | A Award | 2019-05-14 | 2019-05-16 | 100,000 | $0.67 | $67.0K | 199,869 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | M Exercise deriv | 2019-04-23 | 2019-04-25 | 75,000 | — | $0 | 8,359,771 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award | 2019-04-23 | 2019-04-25 | 75,000 | $0.67 | $50.3K | 313,583 | SEC↗ |
| Boehm Rainer J. | Director | A Award | 2019-03-29 | 2019-04-02 | 12,222 | $1.35 | $16.5K | 78,559 | SEC↗ |
| Savage Robert G. | Director | A Award | 2019-03-29 | 2019-04-02 | 13,704 | $1.35 | $18.5K | 99,869 | SEC↗ |
| BARLIANT RONALD | Director | A Award | 2019-03-29 | 2019-04-02 | 10,000 | $1.35 | $13.5K | 170,123 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | M Exercise deriv | 2019-03-08 | 2019-03-11 | 75,000 | — | $0 | 8,434,771 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award | 2019-03-08 | 2019-03-11 | 75,000 | $0.67 | $50.3K | 238,583 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award deriv | 2019-01-25 | 2019-01-28 | 142,857 | — | $0 | 142,857 | SEC↗ |
| Jester J Gregory | Chief Financial Officer | A Award deriv | 2019-01-25 | 2019-01-28 | 86,111 | — | $0 | 86,111 | SEC↗ |
| BARLIANT RONALD | Director | A Award | 2019-01-03 | 2019-01-07 | 18,243 | $0.74 | $13.5K | 160,123 | SEC↗ |
| Boehm Rainer J. | Director | A Award | 2019-01-03 | 2019-01-07 | 18,243 | $0.74 | $13.5K | 66,337 | SEC↗ |
| Savage Robert G. | Director | A Award | 2019-01-03 | 2019-01-07 | 20,946 | $0.74 | $15.5K | 86,165 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award | 2018-12-14 | 2018-12-14 | 4,000 | $0.82 | $3.3K | 163,583 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award | 2018-12-12 | 2018-12-14 | 2,000 | $0.82 | $1.6K | 159,583 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award | 2018-12-11 | 2018-12-12 | 2,500 | $0.76 | $1.9K | 157,583 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award | 2018-12-10 | 2018-12-12 | 2,500 | $0.75 | $1.9K | 155,083 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award | 2018-12-07 | 2018-12-10 | 7,000 | $0.74 | $5.2K | 152,583 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award | 2018-12-06 | 2018-12-10 | 10,000 | $0.73 | $7.3K | 145,583 | SEC↗ |
| Savage Robert G. | Director | A Award | 2018-09-28 | 2018-10-02 | 24,219 | $0.64 | $15.5K | 65,219 | SEC↗ |
| BARLIANT RONALD | Director | A Award | 2018-09-28 | 2018-10-02 | 21,094 | $0.64 | $13.5K | 141,880 | SEC↗ |
| Boehm Rainer J. | Director | A Award | 2018-09-28 | 2018-10-02 | 21,094 | $0.64 | $13.5K | 48,094 | SEC↗ |
| Chappell Dale | 10% Owner | J Other deriv | 2018-09-20 | 2020-04-07 | 0 | $500000.00 | $0 | 0 | SEC↗ |
| BARLIANT RONALD | Director | A Award | 2018-08-07 | 2018-08-09 | 27,000 | $0.50 | $13.5K | 120,786 | SEC↗ |
| Boehm Rainer J. | Director | A Award | 2018-08-07 | 2018-08-09 | 27,000 | $0.50 | $13.5K | 27,000 | SEC↗ |
| Savage Robert G. | Director | A Award | 2018-08-07 | 2018-08-09 | 31,000 | $0.50 | $15.5K | 41,000 | SEC↗ |
| Boehm Rainer J. | Director | A Award deriv | 2018-03-09 | 2018-03-13 | 715,877 | — | $0 | 715,877 | SEC↗ |
| Jester J Gregory | Chief Financial Officer | A Award deriv | 2018-03-09 | 2018-03-13 | 284,313 | — | $0 | 284,313 | SEC↗ |
| Jester J Gregory | Chief Financial Officer | A Award deriv | 2018-03-09 | 2018-03-13 | 1,073,815 | — | $0 | 1,223,815 | SEC↗ |
| BARLIANT RONALD | Director | A Award deriv | 2018-03-09 | 2018-03-13 | 156,863 | — | $0 | 156,863 | SEC↗ |
| BARLIANT RONALD | Director | A Award deriv | 2018-03-09 | 2018-03-13 | 715,877 | — | $0 | 715,877 | SEC↗ |
| Durrant Cameron | Chief Executive Officer | A Award deriv | 2018-03-09 | 2018-03-13 | 7,466,749 | — | $0 | 8,509,771 | SEC↗ |
| Savage Robert G. | Director | A Award deriv | 2018-03-09 | 2018-03-13 | 715,877 | — | $0 | 715,877 | SEC↗ |
| MORRIS TIMOTHY E | Director | A Award deriv | 2018-03-09 | 2018-03-13 | 88,235 | — | $0 | 88,235 | SEC↗ |
| MORRIS TIMOTHY E | Director | A Award deriv | 2018-03-09 | 2018-03-13 | 715,877 | — | $0 | 715,877 | SEC↗ |
| Cheval Holdings, Ltd. | 10% Owner | J Other | 2018-02-27 | 2018-03-01 | 5,123,733 | — | $0 | 5,996,710 | SEC↗ |
| Cheval Holdings, Ltd. | 10% Owner | J Other | 2018-02-27 | 2018-03-01 | 11,957,369 | — | $0 | 13,997,832 | SEC↗ |
| Cheval Holdings, Ltd. | 10% Owner | P Buy | 2018-02-27 | 2018-03-01 | 32,028,669 | $0.09 | $2.88M | 46,876,309 | SEC↗ |
| Cheval Holdings, Ltd. | 10% Owner | J Other | 2018-02-27 | 2018-03-01 | 12,812,322 | — | $0 | 14,847,640 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | P Buy | 2018-02-27 | 2018-03-05 | 29,893,424 | $0.28 | $8.37M | 33,573,530 | SEC↗ |
| Jester J Gregory | Chief Financial Officer | A Award deriv | 2017-09-05 | 2018-03-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NOMIS BAY LTD. | 10% Owner | S Sale | 2017-08-30 | 2017-09-05 | 38,900 | $0.46 | $17.9K | 3,680,106 | SEC↗ |